CORPAY INC (CPAY) Fundamental Analysis & Valuation

NYSE:CPAY • US2199481068

Current stock price

329.93 USD
-7.41 (-2.2%)
At close:
329.93 USD
0 (0%)
After Hours:

This CPAY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. CPAY Profitability Analysis

1.1 Basic Checks

  • In the past year CPAY was profitable.
  • CPAY had a positive operating cash flow in the past year.
  • CPAY had positive earnings in each of the past 5 years.
  • In the past 5 years CPAY always reported a positive cash flow from operatings.
CPAY Yearly Net Income VS EBIT VS OCF VS FCFCPAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

1.2 Ratios

  • With a decent Return On Assets value of 4.05%, CPAY is doing good in the industry, outperforming 73.74% of the companies in the same industry.
  • CPAY's Return On Equity of 27.55% is amongst the best of the industry. CPAY outperforms 92.93% of its industry peers.
  • With an excellent Return On Invested Capital value of 9.95%, CPAY belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CPAY is above the industry average of 8.00%.
Industry RankSector Rank
ROA 4.05%
ROE 27.55%
ROIC 9.95%
ROA(3y)5.33%
ROA(5y)5.8%
ROE(3y)29.87%
ROE(5y)31.29%
ROIC(3y)11.18%
ROIC(5y)11.44%
CPAY Yearly ROA, ROE, ROICCPAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • CPAY has a Profit Margin of 23.62%. This is amongst the best in the industry. CPAY outperforms 81.82% of its industry peers.
  • In the last couple of years the Profit Margin of CPAY has declined.
  • The Operating Margin of CPAY (43.10%) is better than 82.83% of its industry peers.
  • CPAY's Operating Margin has been stable in the last couple of years.
  • CPAY's Gross Margin of 78.60% is amongst the best of the industry. CPAY outperforms 83.84% of its industry peers.
Industry RankSector Rank
OM 43.1%
PM (TTM) 23.62%
GM 78.6%
OM growth 3Y0.7%
OM growth 5Y1.15%
PM growth 3Y-5.33%
PM growth 5Y-4.33%
GM growth 3YN/A
GM growth 5YN/A
CPAY Yearly Profit, Operating, Gross MarginsCPAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. CPAY Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CPAY is creating some value.
  • The number of shares outstanding for CPAY has been reduced compared to 1 year ago.
  • Compared to 5 years ago, CPAY has less shares outstanding
  • The debt/assets ratio for CPAY has been reduced compared to a year ago.
CPAY Yearly Shares OutstandingCPAY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
CPAY Yearly Total Debt VS Total AssetsCPAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.2 Solvency

  • CPAY has an Altman-Z score of 1.54. This is a bad value and indicates that CPAY is not financially healthy and even has some risk of bankruptcy.
  • CPAY has a Altman-Z score of 1.54. This is in the better half of the industry: CPAY outperforms 71.72% of its industry peers.
  • CPAY has a debt to FCF ratio of 7.70. This is a slightly negative value and a sign of low solvency as CPAY would need 7.70 years to pay back of all of its debts.
  • The Debt to FCF ratio of CPAY (7.70) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 2.18 is on the high side and indicates that CPAY has dependencies on debt financing.
  • The Debt to Equity ratio of CPAY (2.18) is worse than 67.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.18
Debt/FCF 7.7
Altman-Z 1.54
ROIC/WACC1.34
WACC7.43%
CPAY Yearly LT Debt VS Equity VS FCFCPAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.3 Liquidity

  • CPAY has a Current Ratio of 0.98. This is a bad value and indicates that CPAY is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.98, CPAY perfoms like the industry average, outperforming 50.51% of the companies in the same industry.
  • CPAY has a Quick Ratio of 0.98. This is a bad value and indicates that CPAY is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of CPAY (0.98) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.98
CPAY Yearly Current Assets VS Current LiabilitesCPAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. CPAY Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 12.47% over the past year.
  • Measured over the past years, CPAY shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.03% on average per year.
  • CPAY shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.93%.
  • CPAY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.64% yearly.
EPS 1Y (TTM)12.47%
EPS 3Y9.92%
EPS 5Y14.03%
EPS Q2Q%12.69%
Revenue 1Y (TTM)13.93%
Revenue growth 3Y9.73%
Revenue growth 5Y13.64%
Sales Q2Q%20.67%

3.2 Future

  • The Earnings Per Share is expected to grow by 17.89% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 10.72% on average over the next years. This is quite good.
EPS Next Y23.59%
EPS Next 2Y18.99%
EPS Next 3Y17.89%
EPS Next 5YN/A
Revenue Next Year16.63%
Revenue Next 2Y13.5%
Revenue Next 3Y12.11%
Revenue Next 5Y10.72%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CPAY Yearly Revenue VS EstimatesCPAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B
CPAY Yearly EPS VS EstimatesCPAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

6

4. CPAY Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 15.43, CPAY is valued correctly.
  • CPAY's Price/Earnings ratio is in line with the industry average.
  • CPAY is valuated rather cheaply when we compare the Price/Earnings ratio to 27.71, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 12.49, the valuation of CPAY can be described as correct.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CPAY is on the same level as its industry peers.
  • When comparing the Price/Forward Earnings ratio of CPAY to the average of the S&P500 Index (38.09), we can say CPAY is valued rather cheaply.
Industry RankSector Rank
PE 15.43
Fwd PE 12.49
CPAY Price Earnings VS Forward Price EarningsCPAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CPAY is valued a bit cheaper than the industry average as 64.65% of the companies are valued more expensively.
  • CPAY's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CPAY is cheaper than 64.65% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.79
EV/EBITDA 11.94
CPAY Per share dataCPAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 -100

4.3 Compensation for Growth

  • CPAY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CPAY has a very decent profitability rating, which may justify a higher PE ratio.
  • CPAY's earnings are expected to grow with 17.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.65
PEG (5Y)1.1
EPS Next 2Y18.99%
EPS Next 3Y17.89%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CPAY Dividend Analysis

5.1 Amount

  • CPAY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CPAY Fundamentals: All Metrics, Ratios and Statistics

CORPAY INC

NYSE:CPAY (4/21/2026, 8:04:00 PM)

After market: 329.93 0 (0%)

329.93

-7.41 (-2.2%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)02-04
Earnings (Next)05-06
Inst Owners97.3%
Inst Owner Change0.32%
Ins Owners3.67%
Ins Owner Change0.13%
Market Cap21.82B
Revenue(TTM)4.53B
Net Income(TTM)1.07B
Analysts83.64
Price Target389.81 (18.15%)
Short Float %3.7%
Short Ratio3.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.66%
Min EPS beat(2)-0.95%
Max EPS beat(2)-0.36%
EPS beat(4)0
Avg EPS beat(4)-1.28%
Min EPS beat(4)-2.03%
Max EPS beat(4)-0.36%
EPS beat(8)0
Avg EPS beat(8)-1.4%
EPS beat(12)1
Avg EPS beat(12)-1.39%
EPS beat(16)4
Avg EPS beat(16)-0.52%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.06%
Max Revenue beat(2)-0.86%
Revenue beat(4)0
Avg Revenue beat(4)-1.61%
Min Revenue beat(4)-2.93%
Max Revenue beat(4)-0.86%
Revenue beat(8)0
Avg Revenue beat(8)-1.96%
Revenue beat(12)1
Avg Revenue beat(12)-2.1%
Revenue beat(16)3
Avg Revenue beat(16)-1.34%
PT rev (1m)0.49%
PT rev (3m)7.54%
EPS NQ rev (1m)-0.13%
EPS NQ rev (3m)-0.04%
EPS NY rev (1m)0.28%
EPS NY rev (3m)4.68%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)0.32%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)0.94%
Valuation
Industry RankSector Rank
PE 15.43
Fwd PE 12.49
P/S 4.82
P/FCF 16.79
P/OCF 14.55
P/B 5.62
P/tB N/A
EV/EBITDA 11.94
EPS(TTM)21.38
EY6.48%
EPS(NY)26.42
Fwd EY8.01%
FCF(TTM)19.65
FCFY5.95%
OCF(TTM)22.68
OCFY6.87%
SpS68.48
BVpS58.73
TBVpS-104.62
PEG (NY)0.65
PEG (5Y)1.1
Graham Number168.085 (-49.05%)
Profitability
Industry RankSector Rank
ROA 4.05%
ROE 27.55%
ROCE 16.12%
ROIC 9.95%
ROICexc 12.12%
ROICexgc 218.24%
OM 43.1%
PM (TTM) 23.62%
GM 78.6%
FCFM 28.69%
ROA(3y)5.33%
ROA(5y)5.8%
ROE(3y)29.87%
ROE(5y)31.29%
ROIC(3y)11.18%
ROIC(5y)11.44%
ROICexc(3y)13.22%
ROICexc(5y)13.72%
ROICexgc(3y)186.24%
ROICexgc(5y)N/A
ROCE(3y)18.08%
ROCE(5y)17.51%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-7.95%
ROICexc growth 5Y2%
OM growth 3Y0.7%
OM growth 5Y1.15%
PM growth 3Y-5.33%
PM growth 5Y-4.33%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 2.18
Debt/FCF 7.7
Debt/EBITDA 3.62
Cap/Depr 51.04%
Cap/Sales 4.43%
Interest Coverage 3.97
Cash Conversion 63.96%
Profit Quality 121.44%
Current Ratio 0.98
Quick Ratio 0.98
Altman-Z 1.54
F-Score6
WACC7.43%
ROIC/WACC1.34
Cap/Depr(3y)48.88%
Cap/Depr(5y)46.57%
Cap/Sales(3y)4.31%
Cap/Sales(5y)4.26%
Profit Quality(3y)165.21%
Profit Quality(5y)137.64%
High Growth Momentum
Growth
EPS 1Y (TTM)12.47%
EPS 3Y9.92%
EPS 5Y14.03%
EPS Q2Q%12.69%
EPS Next Y23.59%
EPS Next 2Y18.99%
EPS Next 3Y17.89%
EPS Next 5YN/A
Revenue 1Y (TTM)13.93%
Revenue growth 3Y9.73%
Revenue growth 5Y13.64%
Sales Q2Q%20.67%
Revenue Next Year16.63%
Revenue Next 2Y13.5%
Revenue Next 3Y12.11%
Revenue Next 5Y10.72%
EBIT growth 1Y11.16%
EBIT growth 3Y10.5%
EBIT growth 5Y14.96%
EBIT Next Year42.93%
EBIT Next 3Y21.02%
EBIT Next 5YN/A
FCF growth 1Y-26.41%
FCF growth 3Y29.13%
FCF growth 5Y-1.4%
OCF growth 1Y-22.71%
OCF growth 3Y25.72%
OCF growth 5Y0.37%

CORPAY INC / CPAY Fundamental Analysis FAQ

What is the fundamental rating for CPAY stock?

ChartMill assigns a fundamental rating of 5 / 10 to CPAY.


What is the valuation status for CPAY stock?

ChartMill assigns a valuation rating of 6 / 10 to CORPAY INC (CPAY). This can be considered as Fairly Valued.


What is the profitability of CPAY stock?

CORPAY INC (CPAY) has a profitability rating of 7 / 10.


What is the valuation of CORPAY INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CORPAY INC (CPAY) is 15.43 and the Price/Book (PB) ratio is 5.62.


How financially healthy is CORPAY INC?

The financial health rating of CORPAY INC (CPAY) is 3 / 10.